Nouscom
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • External presentations
    • Press Releases
    • Scientific publications
    • Conferences
  • Contact
Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • External presentations
    • Press Releases
    • Scientific publications
    • Conferences
  • Contact

Archives

Monthly Archive for: "Ottobre, 2019"
Home » Archivi per Ottobre 2019
0

Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium

Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium on October 22, 2019 in Basel.

READ MORE
0

Nouscom is presenting at the TMB & Neoantigen Congress

Nouscom will present at the TMB & Neoantigen Congress from October 10-11, 2019 in London.

READ MORE
Contact
  • NOUSCOM
  • info@nouscom.com
  • nouscom.com
Our Privacy

Privacy Policy & Cookie Low

Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

© Copyright 2018 | Made with by
error: Content is protected !!!